MiniMed Group Statistics
Total Valuation
MiniMed Group has a market cap or net worth of $4.00 billion. The enterprise value is $4.05 billion.
| Market Cap | 4.00B |
| Enterprise Value | 4.05B |
Important Dates
The last earnings date was Wednesday, June 3, 2026, before market open.
| Earnings Date | Jun 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MiniMed Group has 280.82 million shares outstanding.
| Current Share Class | 280.82M |
| Shares Outstanding | 280.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +6.05% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 11.59% |
| Float | 28.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.42 |
| PS Ratio | 1.29 |
| Forward PS | 1.17 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 3.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.90 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.28% and return on invested capital (ROIC) is -3.11%.
| Return on Equity (ROE) | -9.28% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.11% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $387,750 |
| Profits Per Employee | -$41,375 |
| Employee Count | 8,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MiniMed Group has paid $128.00 million in taxes.
| Income Tax | 128.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.84 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 65.11 |
| Average Volume (20 Days) | 846,454 |
Short Selling Information
The latest short interest is 4.28 million, so 1.52% of the outstanding shares have been sold short.
| Short Interest | 4.28M |
| Short Previous Month | 3.66M |
| Short % of Shares Out | 1.52% |
| Short % of Float | 15.27% |
| Short Ratio (days to cover) | 6.04 |
Income Statement
In the last 12 months, MiniMed Group had revenue of $3.10 billion and -$331.00 million in losses. Loss per share was -$1.29.
| Revenue | 3.10B |
| Gross Profit | 1.68B |
| Operating Income | -172.00M |
| Pretax Income | -187.00M |
| Net Income | -331.00M |
| EBITDA | -16.00M |
| EBIT | -172.00M |
| Loss Per Share | -$1.29 |
Balance Sheet
The company has $10.00 million in cash and $61.00 million in debt, with a net cash position of -$51.00 million or -$0.18 per share.
| Cash & Cash Equivalents | 10.00M |
| Total Debt | 61.00M |
| Net Cash | -51.00M |
| Net Cash Per Share | -$0.18 |
| Equity (Book Value) | 3.46B |
| Book Value Per Share | 12.33 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 156.00M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 54.16%, with operating and profit margins of -5.54% and -10.67%.
| Gross Margin | 54.16% |
| Operating Margin | -5.54% |
| Pretax Margin | -6.03% |
| Profit Margin | -10.67% |
| EBITDA Margin | -0.52% |
| EBIT Margin | -5.54% |
| FCF Margin | n/a |
Dividends & Yields
MiniMed Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -8.28% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MiniMed Group is $20.91, which is 46.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.91 |
| Price Target Difference | 46.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 9.45% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |